Haymaker Acquisition Corp. V
HYAC.WS · NYSE
HYAC.WS key statistics
- Market cap
- —
- Price-earnings ratio
- —
- Dividend yield
- —
- Average volume
- 239.94K
- Volume
- 278.33K
- Open price
- $0.2701
- High today
- $0.30
- Low today
- $0.257
- 52 Week high
- $3.12
- 52 Week low
- $0.35
Haymaker Acquisition Corp. V (HYAC.WS) at a glance
Haymaker Acquisition Corp. V (HYAC.WS) last traded at $0.30 on Nov 18, 2026.
On Nov 18, 2026, the stock traded between $0.257 and $0.30. Its last price was 16.7% above the day's low and 0.0% below its high.
Volume on Nov 18, 2026 reached 278.33K shares, in line with the average of 239.94K shares a day.
Over the past year Haymaker Acquisition Corp. V has ranged from $0.35 to $3.12, and now sits -2% of the way up that range.
Most active stocks
Highest trading volume today
- RDARRaadr$0.0002+0.00%
- ANTAnthropic PBC$95.03
- VIVSVivoSim Labs$0.2934+144.50%
- AITXArtificial Intelligence Technology Solutions$0.0002+0.00%
- KOANResonate Blends$0.0001−50.00%
- CHSNChanson International Holding$0.099−2.94%
- SOXLDirexion Shares ETF Trust$46.11−6.39%
- NVDANVIDIA$147.59−2.23%
- SPDNDirexion Shares ETF Trust$9.06+1.80%
- AXXAExxe Group$0.0004−12.50%
- INNDInnerscope Hearing Technologies$0.0002+33.33%
- LIVGLivento Group$0.0001+0.00%
Newly listed
Companies that went public in the past six weeks
- WWBWINDWARD BIO GROUP AG$23.27+2.78%
- VVVVvVARDIS Holding AG$15.03−2.88%
- MDRNModern Mining Technology$2.30+40.80%
- NARANarragansett Bancorp$10.20−2.49%
- ASPEAspen Neuroscience$12.47+3.79%
- BBTXBambusa Therapeutics$15.57−2.08%
- GBCGEORGIA BANKING$33.80−1.31%
- BHAIUBHAV Acquisition Corp II$10.00−0.10%
- SCQCUSPACCircle Acquisition$10.01+0.10%
- LYCALycia Therapeutics$32.35+3.19%
- DAVIDAVION HEALTHCARE$0.9988−6.65%
- TCXBTCGX Acquisition Corp. II$10.40+2.36%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.